SPONSOR
Shanghai Chest Hospital
Total Trials
6
Recruiting
6
Phases
Phase 3, Phase 2, Phase 1, Phase 1, Phase 2
Conditions studied: Stage II-III Non-small Cell Lung CancerLung CancerLung Cancer, Small CellLung Cancer (NSCLC)Leptomeningeal MetastasisPONVNon-Small Cell Lung CancerLocally Advanced Non-Small Cell Lung CancerUnresectable Stage III NSCLC
Shanghai Chest Hospital is a clinical research sponsor with 6 registered studies on ClinicalTrials.gov, of which 6 are actively recruiting participants. Research covers conditions including Stage II-III Non-small Cell Lung Cancer, Lung Cancer, Lung Cancer, Small Cell, Lung Cancer (NSCLC).
The trial portfolio spans Phase 3, Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Shanghai Chest Hospital
How many clinical trials has Shanghai Chest Hospital sponsored?
ClinicalMetric currently tracks 6 clinical trials sponsored by Shanghai Chest Hospital, of which 6 are actively recruiting participants. These trials cover conditions including Stage II-III Non-small Cell Lung Cancer, Lung Cancer, Lung Cancer, Small Cell. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Shanghai Chest Hospital research focus on?
Shanghai Chest Hospital clinical trials span Stage II-III Non-small Cell Lung Cancer, Lung Cancer, Lung Cancer, Small Cell, Lung Cancer (NSCLC), Leptomeningeal Metastasis, and additional conditions. The research pipeline includes Phase 3, Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Shanghai Chest Hospital clinical trial?
To participate in a Shanghai Chest Hospital trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Shanghai Chest Hospital trials with current recruitment status updated daily.
Clinical Trials by Shanghai Chest Hospital
NCT06437977 Phase 3
Recruiting
Neoadjuvant Therapy of SBRT Sequencial With Toripalimab and Chemotherapy in Resectable Stage II-III NSCLC Patients(neoR-TORCH)
Stage II-III Non-small Cell Lung Cancer
NCT06483295
Recruiting
Improving Patient-reported Outcomes After Lung Cancer Surgery With Mobile Internet Platform
Lung Cancer
NCT06698965 Phase 2
Recruiting
Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin
Lung Cancer, Small Cell
NCT06663306 Phase 1
Recruiting
Intrathecal Injection Pemetrexed And Bevacizumab in Patients With Leptomeningeal Metastases in NSCLC
Lung Cancer (NSCLC)
NCT07515027
Recruiting
Electroacupuncture Plus 5-HT3 Receptor Inhibitor for PONV Prevention in High-Risk Patients Undergoing Thoracoscopic Lung Cancer Surgery
PONV
NCT07632365 Phase 1, Phase 2
Recruiting
Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation Immunotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology